Zambia / Mozambique / South Africa / Uganda / United States / Tanzania / United Kingdom / / /
Event
FDA Phase / /
Facility
Medical Research Council Uganda Virus Research Institute / Mavalane Hospital / Imperial College / University Teaching Hospital / National Institute / Health Research Centre / St. George’s Hospital / University of Witwatersrand / /
IndustryTerm
media queries / HIV prevention / pharmaceutical / energy / /
MedicalCondition
HIV / epidemic / HIV infections / HIV infection / cancer / sexually transmitted infections / HIV/AIDS / /
MedicalTreatment
counselling / /
Organization
National Institute of Health / UK Department for International Development / Imperial College London / National Institute for Medical Research / St. George’s Hospital / Clinical Trials Unit / South African Medical Research Council / Mavalane Hospital in Maputo / London School of Hygiene and Tropical Medicine / Medical Research Council Uganda Virus Research Institute / Department of Obstetrics and Gynaecology / Health Research Centre / MDP Programme Management Board / Reproductive Health and HIV Research Unit / Africa Centre for Health and Population Studies / University of Witwatersrand / Johannesburg / UK Medical Research Council / African Medical and Research Foundation / Division of Medicine / University Teaching Hospital / Barcelona Centre for International Health Research / /
Person
Sheena McCormack / Sibone Mocumbi / Gita Ramjee / Jonathan Weber / Helen Rees / Richard Hayes / Wendy Stevens / Anatoli Kamali / Maureen Chisembele / / /
Position
Principal Investigator / tackle research / tackle / Professor / co-Chair / Chief Investigator / /
HIV ‘prevention’ gel PRO 2000 proven ineffective (Embargoed until 07:00 14 December 2009 GMT) 14 December[removed]The largest international clinical trial to date into a preventative HIV gel has found